Page last updated: 2024-11-12

rosmanol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

rosmanol: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID13966122
CHEMBL ID507166
SCHEMBL ID459610
MeSH IDM0438979

Synonyms (21)

Synonym
rosmanol
CHEMBL507166
AKOS016004074
2h-10,4a-(epoxymethano)phenanthren-12-one, 1,3,4,9,10,10a-hexahydro-5,6,9-trihydroxy-1,1-dimethyl-7-(1-methylethyl)-, (4ar-(4a.alpha.,9.beta.,10.alpha.,10a.beta.))-
2h-10,4a-(epoxymethano)phenanthren-12-one, 1,3,4,9,10,10a-hexahydro-5,6,9-trihydroxy-1,1-dimethyl-7-(1-methylethyl)-, (4ar,9s,10s,10as)-
F25TV383OC ,
33985-86-3
(6beta,7alpha)-7,11,12-trihydroxy-6,20-epoxyabieta-8(14),9(11),12-trien-20-one
unii-f25tv383oc
2h-10,4a-(epoxymethano)phenanthren-12-one, 1,3,4,9,10,10a-hexahydro-5,6,9-trihydroxy-1,1-dimethyl-7-(1-methylethyl)-, (4ar-(4aalpha,9beta,10alpha,10abeta))-
80225-53-2
SCHEMBL459610
(4br,8as,9s,10s)-3,4,10-trihydroxy-2-isopropyl-8,8-dimethyl-6,7,8,8a,9,10-hexahydro-5h-9,4b-(epoxymethano)phenanthren-12-one
AC-34511
DTXSID80553423
CS-0032078
HY-N5015
Q27277536
(1r,8s,9s,10s)-3,4,8-trihydroxy-11,11-dimethyl-5-propan-2-yl-16-oxatetracyclo[7.5.2.01,10.02,7]hexadeca-2,4,6-trien-15-one
D85077
MS-25326

Research Excerpts

Overview

Rosmanol is a natural polyphenol from the herb rosemary (Rosmarinus officinalis L.) with high antioxidant activity.

ExcerptReferenceRelevance
"Rosmanol is a natural polyphenol from the herb rosemary (Rosmarinus officinalis L.) with high antioxidant activity. "( Rosmanol potently inhibits lipopolysaccharide-induced iNOS and COX-2 expression through downregulating MAPK, NF-kappaB, STAT3 and C/EBP signaling pathways.
Ho, CT; Lai, CS; Lee, JH; Liu, CB; Pan, MH; Wang, JM; Wang, YJ, 2009
)
3.24

Treatment

ExcerptReferenceRelevance
"Treatment with rosmanol also reduced translocation of the nuclear factor-kappaB (NF-kappaB) subunits by prevention of the degradation and phosphorylation of inhibitor kappaB (IkappaB)."( Rosmanol potently inhibits lipopolysaccharide-induced iNOS and COX-2 expression through downregulating MAPK, NF-kappaB, STAT3 and C/EBP signaling pathways.
Ho, CT; Lai, CS; Lee, JH; Liu, CB; Pan, MH; Wang, JM; Wang, YJ, 2009
)
2.14

Bioavailability

ExcerptReferenceRelevance
" The aim of this study was to investigate the bioavailability of these compounds in a rat model of obesity."( Bioavailability of the major bioactive diterpenoids in a rosemary extract: metabolic profile in the intestine, liver, plasma, and brain of Zucker rats.
Espín, JC; Flanagan, J; Fromentin, E; García Villalba, R; García-Conesa, MT; Larrosa, M; Roller, M; Romo Vaquero, M; Tomás-Barberán, FA; Yáñez-Gascón, MJ, 2013
)
0.39

Dosage Studied

ExcerptRelevanceReference
" In addition, the polyphenols dose-response correlations with cellular antioxidant activity were also determined."( Antioxidant activity evaluation of rosemary ethanol extract and their cellular antioxidant activity toward HeLa cells.
Jiang, ZT; Li, R; Nie, JY; Tan, J; Tang, SH; Wang, Y, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (51)

Assay IDTitleYearJournalArticle
AID471604Cytotoxicity against human A549 cells at lag phase of growth after 48 hrs by MTT assay2009Journal of natural products, Aug, Volume: 72, Issue:8
Semisynthesis and biological evaluation of abietane-type diterpenes. Revision of the structure of rosmaquinone.
AID1756071Antibiofilm activity against Escherichia coli DSM 8579 assessed as inhibition of biofilm formation at 40 ug/ml measured after 48 hrs by crystal violet staining based assay relative to control
AID335102Inhibition of bovine spleen cathepsin D up to 10 ug/ml1993Journal of natural products, Aug, Volume: 56, Issue:8
Inhibitory effect of carnosic acid on HIV-1 protease in cell-free assays [corrected].
AID471598Antibacterial activity against Pseudomonas aeruginosa AK958 after 24 hrs by broth dilution assay2009Journal of natural products, Aug, Volume: 72, Issue:8
Semisynthesis and biological evaluation of abietane-type diterpenes. Revision of the structure of rosmaquinone.
AID1756084Antibiofilm activity against Escherichia coli DSM 8579 assessed as inhibition of bacterial metabolism within the biofilm at 80 ug/ml measured after 48 hrs by MTT assay relative to control
AID1756077Antibiofilm activity against Pectobacterium carotovorum ATCC 15713 assessed as inhibition of bacterial metabolism within the biofilm at 4 ug/ml measured after 48 hrs by MTT assay relative to control
AID471602Cytotoxicity against human Hep2 cells at lag phase of growth after 48 hrs by MTT assay2009Journal of natural products, Aug, Volume: 72, Issue:8
Semisynthesis and biological evaluation of abietane-type diterpenes. Revision of the structure of rosmaquinone.
AID744357Activation of Nrf2/ARE in E15 stage mouse primary cortical neurons after 48 hrs by human placental alkaline phosphatase reporter gene assay2013Bioorganic & medicinal chemistry, May-01, Volume: 21, Issue:9
Structure activity relationship of phenolic diterpenes from Salvia officinalis as activators of the nuclear factor E2-related factor 2 pathway.
AID471356Antibacterial activity against Bacillus cereus ATCC 21772 after 24 hrs by broth dilution assay2009Journal of natural products, Aug, Volume: 72, Issue:8
Semisynthesis and biological evaluation of abietane-type diterpenes. Revision of the structure of rosmaquinone.
AID471605Cytotoxicity against human A549 cells at exponential phase of growth after 48 hrs by MTT assay2009Journal of natural products, Aug, Volume: 72, Issue:8
Semisynthesis and biological evaluation of abietane-type diterpenes. Revision of the structure of rosmaquinone.
AID1756076Antibiofilm activity against Acinetobacter baumannii ATCC 19606 assessed as inhibition of bacterial metabolism within the biofilm at 4 ug/ml measured after 48 hrs by MTT assay relative to control
AID1756070Antibiofilm activity against Pectobacterium carotovorum ATCC 15713 assessed as inhibition of biofilm formation at 8 ug/ml measured after 48 hrs by crystal violet staining based assay relative to control
AID1756079Antibiofilm activity against Pseudomonas aeruginosa ATCC 50071 assessed as inhibition of bacterial metabolism within the biofilm at 8 ug/ml measured after 48 hrs by MTT assay relative to control
AID471601Cytotoxicity against human HeLa cells at exponential phase of growth after 48 hrs by MTT assay2009Journal of natural products, Aug, Volume: 72, Issue:8
Semisynthesis and biological evaluation of abietane-type diterpenes. Revision of the structure of rosmaquinone.
AID471357Antibacterial activity against Candida albicans CECT 170 after 24 hrs by broth dilution assay2009Journal of natural products, Aug, Volume: 72, Issue:8
Semisynthesis and biological evaluation of abietane-type diterpenes. Revision of the structure of rosmaquinone.
AID471358Antibacterial activity against Enterococcus faecalis ATCC 29212 after 24 hrs by broth dilution assay2009Journal of natural products, Aug, Volume: 72, Issue:8
Semisynthesis and biological evaluation of abietane-type diterpenes. Revision of the structure of rosmaquinone.
AID471608Cytotoxicity against african green monkey Vero cells at lag phase of growth after 48 hrs by MTT assay2009Journal of natural products, Aug, Volume: 72, Issue:8
Semisynthesis and biological evaluation of abietane-type diterpenes. Revision of the structure of rosmaquinone.
AID1756072Antibiofilm activity against Escherichia coli DSM 8579 assessed as inhibition of biofilm formation at 80 ug/ml measured after 48 hrs by crystal violet staining based assay relative to control
AID1603993Induction of apoptosis in human COLO205 cells after 24 hrs2019European journal of medicinal chemistry, Nov-01, Volume: 181The Mediterranean Diet as source of bioactive compounds with multi-targeting anti-cancer profile.
AID471603Cytotoxicity against human Hep2 cells at exponential phase of growth after 48 hrs by MTT assay2009Journal of natural products, Aug, Volume: 72, Issue:8
Semisynthesis and biological evaluation of abietane-type diterpenes. Revision of the structure of rosmaquinone.
AID471354Antibacterial activity against Staphylococcus epidermidis ATCC 14990 after 24 hrs by broth dilution assay2009Journal of natural products, Aug, Volume: 72, Issue:8
Semisynthesis and biological evaluation of abietane-type diterpenes. Revision of the structure of rosmaquinone.
AID471355Antibacterial activity against Bacillus subtilis ATCC 6051 after 24 hrs by broth dilution assay2009Journal of natural products, Aug, Volume: 72, Issue:8
Semisynthesis and biological evaluation of abietane-type diterpenes. Revision of the structure of rosmaquinone.
AID1756063Antibiofilm activity against Staphylococcus aureus ATCC 25923 assessed as inhibition of biofilm formation at 4 ug/ml measured after 48 hrs by crystal violet staining based assay relative to control
AID1756075Antibiofilm activity against Staphylococcus aureus ATCC 25923 assessed as inhibition of bacterial metabolism within the biofilm at 4 ug/ml measured after 48 hrs by MTT assay relative to control
AID1756069Antibiofilm activity against Acinetobacter baumannii ATCC 19606 assessed as inhibition of biofilm formation at 8 ug/ml measured after 48 hrs by crystal violet staining based assay relative to control
AID471609Cytotoxicity against african green monkey Vero cells at exponential phase of growth after 48 hrs by MTT assay2009Journal of natural products, Aug, Volume: 72, Issue:8
Semisynthesis and biological evaluation of abietane-type diterpenes. Revision of the structure of rosmaquinone.
AID1756066Antibiofilm activity against Listeria monocytogenes ATCC 7644 assessed as inhibition of biofilm formation at 8 ug/ml measured after 48 hrs by crystal violet staining based assay relative to control
AID471599Antibacterial activity against Salmonella CECT 4569 after 24 hrs by broth dilution assay2009Journal of natural products, Aug, Volume: 72, Issue:8
Semisynthesis and biological evaluation of abietane-type diterpenes. Revision of the structure of rosmaquinone.
AID1756062Antibiofilm activity against Pseudomonas aeruginosa ATCC 50071 assessed as inhibition of biofilm formation at 4 ug/ml measured after 48 hrs by crystal violet staining based assay relative to control
AID335101Inhibition of HIV1 recombinant protease expressed in Escherichia coli BL21 (DE3) cells by SDS-PAGE1993Journal of natural products, Aug, Volume: 56, Issue:8
Inhibitory effect of carnosic acid on HIV-1 protease in cell-free assays [corrected].
AID1756065Antibiofilm activity against Pectobacterium carotovorum ATCC 15713 assessed as inhibition of biofilm formation at 4 ug/ml measured after 48 hrs by crystal violet staining based assay relative to control
AID335105Inhibition of pig pepsin up to 10 ug/ml1993Journal of natural products, Aug, Volume: 56, Issue:8
Inhibitory effect of carnosic acid on HIV-1 protease in cell-free assays [corrected].
AID1756061Antibiofilm activity against Listeria monocytogenes ATCC 7644 assessed as inhibition of biofilm formation at 4 ug/ml measured after 48 hrs by crystal violet staining based assay relative to control
AID471597Antibacterial activity against Proteus mirabilis CECT 170 after 24 hrs by broth dilution assay2009Journal of natural products, Aug, Volume: 72, Issue:8
Semisynthesis and biological evaluation of abietane-type diterpenes. Revision of the structure of rosmaquinone.
AID1756078Antibiofilm activity against Listeria monocytogenes ATCC 7644 assessed as inhibition of bacterial metabolism within the biofilm at 8 ug/ml measured after 48 hrs by MTT assay relative to control
AID1756067Antibiofilm activity against Pseudomonas aeruginosa ATCC 50071 assessed as inhibition of biofilm formation at 8 ug/ml measured after 48 hrs by crystal violet staining based assay relative to control
AID1756083Antibiofilm activity against Escherichia coli DSM 8579 assessed as inhibition of bacterial metabolism within the biofilm at 40 ug/ml measured after 48 hrs by MTT assay relative to control
AID471607Cytotoxicity against human sMCF7 cells at exponential phase of growth after 48 hrs by MTT assay2009Journal of natural products, Aug, Volume: 72, Issue:8
Semisynthesis and biological evaluation of abietane-type diterpenes. Revision of the structure of rosmaquinone.
AID1756073Antibiofilm activity against Listeria monocytogenes ATCC 7644 assessed as inhibition of bacterial metabolism within the biofilm at 4 ug/ml measured after 48 hrs by MTT assay relative to control
AID1756068Antibiofilm activity against Staphylococcus aureus ATCC 25923 assessed as inhibition of biofilm formation at 8 ug/ml measured after 48 hrs by crystal violet staining based assay relative to control
AID471606Cytotoxicity against human MCF7 cells at lag phase of growth after 48 hrs by MTT assay2009Journal of natural products, Aug, Volume: 72, Issue:8
Semisynthesis and biological evaluation of abietane-type diterpenes. Revision of the structure of rosmaquinone.
AID1756074Antibiofilm activity against Pseudomonas aeruginosa ATCC 50071 assessed as inhibition of bacterial metabolism within the biofilm at 4 ug/ml measured after 48 hrs by MTT assay relative to control
AID1756080Antibiofilm activity against Staphylococcus aureus ATCC 25923 assessed as inhibition of bacterial metabolism within the biofilm at 8 ug/ml measured after 48 hrs by MTT assay relative to control
AID1603994Induction of apoptosis in human COLO205 cells after 24 hrs relative to control2019European journal of medicinal chemistry, Nov-01, Volume: 181The Mediterranean Diet as source of bioactive compounds with multi-targeting anti-cancer profile.
AID744356Activation of Nrf2/ARE in E15 stage mouse primary cortical neurons at 6.25 to 50 uM after 48 hrs by human placental alkaline phosphatase reporter gene assay2013Bioorganic & medicinal chemistry, May-01, Volume: 21, Issue:9
Structure activity relationship of phenolic diterpenes from Salvia officinalis as activators of the nuclear factor E2-related factor 2 pathway.
AID1756082Antibiofilm activity against Pectobacterium carotovorum ATCC 15713 assessed as inhibition of bacterial metabolism within the biofilm at 8 ug/ml measured after 48 hrs by MTT assay relative to control
AID471600Cytotoxicity against human HeLa cells at lag phase of growth after 48 hrs by MTT assay2009Journal of natural products, Aug, Volume: 72, Issue:8
Semisynthesis and biological evaluation of abietane-type diterpenes. Revision of the structure of rosmaquinone.
AID1756064Antibiofilm activity against Acinetobacter baumannii ATCC 19606 assessed as inhibition of biofilm formation at 4 ug/ml measured after 48 hrs by crystal violet staining based assay relative to control
AID471353Antibacterial activity against Staphylococcus aureus ATCC 6538 after 24 hrs by broth dilution assay2009Journal of natural products, Aug, Volume: 72, Issue:8
Semisynthesis and biological evaluation of abietane-type diterpenes. Revision of the structure of rosmaquinone.
AID471596Antibacterial activity against Escherichia coli ATCC 9637 after 24 hrs by broth dilution assay2009Journal of natural products, Aug, Volume: 72, Issue:8
Semisynthesis and biological evaluation of abietane-type diterpenes. Revision of the structure of rosmaquinone.
AID1756081Antibiofilm activity against Acinetobacter baumannii ATCC 19606 assessed as inhibition of bacterial metabolism within the biofilm at 8 ug/ml measured after 48 hrs by MTT assay relative to control
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (21)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (4.76)18.2507
2000's9 (42.86)29.6817
2010's8 (38.10)24.3611
2020's3 (14.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 31.88

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index31.88 (24.57)
Research Supply Index3.18 (2.92)
Research Growth Index5.39 (4.65)
Search Engine Demand Index39.34 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (31.88)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (13.04%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (86.96%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]